CTI BioPharma (CTIC) Misses Q4 EPS by 4c

March 7, 2018 4:04 PM

CTI BioPharma (NASDAQ: CTIC) reported Q4 EPS of ($0.33), $0.04 worse than the analyst estimate of ($0.29).

For earnings history and earnings-related data on CTI BioPharma (CTIC) click here.

Categories

Earnings Guidance